Artera Product Webinar April 2026 April 20, 2026
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating prostate cancer. For lower-risk patients, the test results can guide patient suitability for active surveillance. For intermediate-risk patients, there’s a predictive test result to determine if ST-ADT is beneficial. For high-risk patients, there’s insights to guide abiraterone usage along with radiation therapy and LT-ADT. And for recurrent patients after prostatectomy, the test can help guide ADT use alongside salvage radiation.
Listen to Drs. Ken Nepple, Murilo de Almeida Luz, and Ben Fischer-Valuck on how they’ve incorporated the test into their workflows and how it’s impacted patients in their prostate cancer care. They review real-world case examples, specifically biochemical recurrent cases post radical prostatectomy, and how the test results helped determine adjunctive ADT usage.
Fill out the form below to view the recording…
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating prostate cancer. For lower-risk patients, the test results can guide patient suitability for active surveillance. For intermediate-risk patients, there’s a predictive test result to determine if ST-ADT is beneficial. For high-risk patients, there’s insights to guide abiraterone usage along with radiation therapy and LT-ADT. And for recurrent patients after prostatectomy, the test can help guide ADT use alongside salvage radiation.
Listen to Drs. Ken Nepple, Murilo de Almeida Luz, and Ben Fischer-Valuck on how they’ve incorporated the test into their workflows and how it’s impacted patients in their prostate cancer care. They review real-world case examples, specifically biochemical recurrent cases post radical prostatectomy, and how the test results helped determine adjunctive ADT usage.
Related Articles
AUA 2024 Prostate Talk
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. The Arte [...]
Artera Product Webinar – May
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch th [...]